IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.9600
+0.0372 (4.03%)
Apr 25, 2025, 4:00 PM EDT - Market closed

IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $63.25 million. The enterprise value is $5.13 million.

Market Cap 63.25M
Enterprise Value 5.13M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 51.31% in one year.

Current Share Class 65.88M
Shares Outstanding 65.88M
Shares Change (YoY) +51.31%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.34%
Owned by Institutions (%) 15.40%
Float 31.42M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.35
P/TBV Ratio 1.35
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.04.

Current Ratio 3.33
Quick Ratio 3.14
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -106.00% and return on invested capital (ROIC) is -64.45%.

Return on Equity (ROE) -106.00%
Return on Assets (ROA) -54.47%
Return on Invested Capital (ROIC) -64.45%
Return on Capital Employed (ROCE) -197.41%
Revenue Per Employee n/a
Profits Per Employee -$1.19M
Employee Count 80
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, IO Biotech has paid $1.44 million in taxes.

Income Tax 1.44M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.25% in the last 52 weeks. The beta is 0.08, so IO Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.08
52-Week Price Change -34.25%
50-Day Moving Average 0.96
200-Day Moving Average 1.05
Relative Strength Index (RSI) 52.67
Average Volume (20 Days) 146,125

Short Selling Information

The latest short interest is 112,344, so 0.17% of the outstanding shares have been sold short.

Short Interest 112,344
Short Previous Month 128,332
Short % of Shares Out 0.17%
Short % of Float 0.36%
Short Ratio (days to cover) 0.45

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -95.18M
Pretax Income -87.64M
Net Income -95.49M
EBITDA -94.92M
EBIT -95.18M
Earnings Per Share (EPS) -$1.45
Full Income Statement

Balance Sheet

The company has $60.03 million in cash and $1.92 million in debt, giving a net cash position of $58.12 million or $0.88 per share.

Cash & Cash Equivalents 60.03M
Total Debt 1.92M
Net Cash 58.12M
Net Cash Per Share $0.88
Equity (Book Value) 47.02M
Book Value Per Share 0.71
Working Capital 45.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$82.35 million and capital expenditures -$44,000, giving a free cash flow of -$82.39 million.

Operating Cash Flow -82.35M
Capital Expenditures -44,000
Free Cash Flow -82.39M
FCF Per Share -$1.25
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -51.31%
Shareholder Yield n/a
Earnings Yield -150.98%
FCF Yield -130.27%

Analyst Forecast

The average price target for IO Biotech is $9.33, which is 871.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.33
Price Target Difference 871.88%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1